These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 4404295)

  • 21. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of a hallucinolytic, azacyclonol chlorhydrate (concentrated frenquel: Laboratoire Toraude)].
    Haumonte T; Lefèvre E; Wurtz D
    Ann Med Psychol (Paris); 1968 Nov; 2(4):575-81. PubMed ID: 5709616
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic management, the hospital environment].
    Gayral L
    Encephale; 1970; ():Suppl:19-25. PubMed ID: 5458709
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and ambulatory experiences with fluphenazine decanoate lyogen depot in prolonged therapy of psychiatric disorders].
    Moldenhauer B
    Med Welt; 1970 Jun; 25():1150-4. PubMed ID: 5512636
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
    Elley JH; Petersen JH
    Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 30. [Considerations on the use of long-acting neuroleptics in a mental health center].
    Carotti P; Merli R
    Minerva Med; 1986 Sep; 77(34-35):1577-83. PubMed ID: 2876402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
    Robak OH
    Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experience with 19.552 R.P. in Nordic countries.
    Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 246():42-7. PubMed ID: 4148911
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine enanthate.
    Ahlfors UG
    Acta Psychiatr Scand Suppl; 1973; 241():95-9. PubMed ID: 4147516
    [No Abstract]   [Full Text] [Related]  

  • 34. [Depot neuroleptics].
    Rainaut J
    Evol Psychiatr (Paris); 1970; 35(14):897-952. PubMed ID: 4396338
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical therapeutic experiences with fluphenazine].
    Pfeiffer WM
    Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
    [No Abstract]   [Full Text] [Related]  

  • 36. [Withdrawal of delayed-action neuroleptics in psychotic patients].
    Maillard M; Coutanceau R; Marchina JC
    Ann Med Psychol (Paris); 1979; 137(3-4):351-5. PubMed ID: 40514
    [No Abstract]   [Full Text] [Related]  

  • 37. Lowest effective dose of depot neuroleptics.
    Hoencamp E; Haffmans PJ; Jansen GS
    Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.
    Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 241():51-6. PubMed ID: 4147511
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
    López-Ibor Aliño JM
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
    [No Abstract]   [Full Text] [Related]  

  • 40. Depot antipsychotics in practice. Their rôle in schizophrenia and related psychoses.
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-78. PubMed ID: 2881965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.